Data / Federal awards / NAICS 541715 / THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK: 52 federal contract awards, $6.8 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (UEI QHF5ZZ114M72), New York, NY, received 52 federal prime contract awards with $6.8 million obligated in fiscal years 2024 to 2027, from 5 agencies under 13 NAICS codes. Its largest buyer is Department of Health and Human Services ($7.3 million) and its largest code is NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The request: Every federal contract awarded under NAICS 541715, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- QHF5ZZ114M72
- Location
- New York, NY
- Business size
- Other Than Small Business
- Contract awards
- 52
- Obligated
- $6.8 million
- First action in window
- 2023-11-22
- Latest action
- 2026-09-25
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 19 | $4.2 million |
| 541512 | Computer Systems Design Services | 1 | $1.1 million |
| 622110 | General Medical and Surgical Hospitals | 3 | $936,504 |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 8 | $922,694 |
| 541380 | Testing Laboratories and Services | 4 | $314,311 |
| 541720 | Research and Development in the Social Sciences and Humanities | 2 | $247,055 |
| 611710 | Educational Support Services | 3 | $172,546 |
| 541712 | Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) | 4 | $81,258 |
| 334516 | Analytical Laboratory Instrument Manufacturing | 1 | $29,000 |
| 325413 | In-Vitro Diagnostic Substance Manufacturing | 1 | $-27,325 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 44 | $7.3 million |
| Department of Defense | 1 | $359,900 |
| Department of State | 4 | $288,084 |
| National Aeronautics and Space Administration | 1 | $0 |
| Department of Veterans Affairs | 2 | $-1,123,220 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $7.5 million |
| FY2025 | $-155,925 |
| FY2026 | $-509,152 |
Contract awards
The 50 largest of 52 awards by dollars obligated in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75N92024F00001 | Department of Health and Human Services | Delivery Order | 541715 | REDS-IV-P DOMESTIC HUBS | $1,656,603 | $1,656,603 | July 1, 2024 | March 7, 2025 | New York, NY | usaspending.gov |
| 75N93023C00041 | Department of Health and Human Services | Definitive Contract | 541512 | A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES | $1,089,350 | $2,501,040 | September 30, 2023 | March 7, 2025 | New York, NY | usaspending.gov |
| 75N98026F00002 | Department of Health and Human Services | Delivery Order | 541715 | RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) REGIONAL HUBS | $829,129 | $829,129 | September 30, 2026 | September 29, 2027 | New York, NY | usaspending.gov |
| 75D30124F00002 | Department of Health and Human Services | Delivery Order | 622110 | CISA RSV INFANTS STUDY (CONTRIBUTING SITE) | $767,661 | $767,661 | September 27, 2024 | September 26, 2027 | Durham, NC | usaspending.gov |
| 75N98026F00001 | Department of Health and Human Services | Delivery Order | 541715 | RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) | $763,760 | $763,760 | September 30, 2026 | September 29, 2027 | New York, NY | usaspending.gov |
| 75N94025F00001 | Department of Health and Human Services | Delivery Order | 541714 | NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVE | $539,573 | $539,573 | September 29, 2025 | December 31, 2027 | New York, NY | usaspending.gov |
| 75N92026F00001 | Department of Health and Human Services | Delivery Order | 541715 | MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A | $437,119 | $437,119 | February 13, 2026 | December 18, 2026 | Bethesda, MD | usaspending.gov |
| 75N92020F00001 | Department of Health and Human Services | Delivery Order | 541715 | TASK AREA A SHALL ENCOMPASS ANNUAL FOLLOW-UP OF COHORT MEMBERS, CLINICAL EVENTS INVESTIGATIONS, STUDY OPERATIONS, AND DATA ANALYSIS AND MANU | $419,151 | $1,960,053 | December 19, 2019 | December 18, 2024 | New York, NY | usaspending.gov |
| W913E524C0028 | Department of Defense | Definitive Contract | 541715 | CSO - AUTOMATED SOLUTION FOR COLD CULTIVATION CULTUROMICS U437N00 | $359,900 | $359,900 | September 26, 2024 | March 7, 2025 | New York, NY | usaspending.gov |
| 75D30124P18698 | Department of Health and Human Services | Purchase Order | 541720 | PROSPECTIVE LONG-TERM FOLLOW-UP OF COVID 19 INFECTION WITH NEUROLOGICAL MANIFESTATIONS | $249,000 | $249,000 | April 24, 2024 | June 30, 2025 | Atlanta, GA | usaspending.gov |
| 75F40124C00081 | Department of Health and Human Services | Definitive Contract | 541714 | CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP | $237,268 | $237,268 | September 16, 2024 | March 7, 2025 | New York, NY | usaspending.gov |
| 19VM3025P0594 | Department of State | Purchase Order | 541380 | HANOINAMRU-IP_VIRCAPSEQ-VERT PROBE SET AND TWIST REAGENTS | $190,084 | $190,084 | July 27, 2025 | September 29, 2025 | Vietnam | usaspending.gov |
| 75N92025F00001 | Department of Health and Human Services | Delivery Order | 541715 | MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | $186,106 | $186,106 | December 19, 2024 | March 7, 2025 | Rockville, MD | usaspending.gov |
| 75F40124F19003 | Department of Health and Human Services | Delivery Order | 611710 | (BEST) INITIATIVE: COMMUNITY ENGAGEMENT AND DEVELOPMENT INITIATIVE FOR A CONVENER ORGANIZATION TO PROVIDE THE FDA WITH SUPPORT TO COLLABORAT | $172,546 | $172,546 | September 26, 2024 | March 7, 2025 | New York, NY | usaspending.gov |
| 75D30123F00001 | Department of Health and Human Services | Delivery Order | 622110 | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | $168,843 | $229,774 | September 28, 2023 | September 27, 2027 | New York, NY | usaspending.gov |
| 75F40123C00211 | Department of Health and Human Services | Definitive Contract | 541714 | THE OBJECTIVES OF THE PROPOSED STUDY ARE TO EXAMINE THE EFFECTS OF POSTNATAL MANAGEMENT APPROACHES (NON-PHARMACOLOGICAL, INCLUDING ESC VERSU | $83,040 | $520,616 | September 25, 2023 | June 27, 2025 | Silver Spring, MD | usaspending.gov |
| 75N94018F00005 | Department of Health and Human Services | Delivery Order | 541712 | IGF::OT::IGF CORE FUNCTION ACTIVITIES TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PR | $81,947 | $516,723 | September 25, 2018 | July 14, 2026 | New York, NY | usaspending.gov |
| 75F40124C00087 | Department of Health and Human Services | Definitive Contract | 541714 | BAAFDA-24-00123, REFERENCE FY24C3DP2: SYSTEMATIC REVIEW OF NEURODEVELOPMENTAL OUTCOME IN VULNERABLE PEDIATRIC PATIENT POPULATIONS | $48,448 | $48,448 | August 15, 2024 | March 7, 2025 | New York, NY | usaspending.gov |
| 75N95023P00861 | Department of Health and Human Services | Purchase Order | 541380 | IN VIVO TESTING OF A LEAD COQ10 BIOSYNTHESIS INHIBITOR IN AN SK-BR-3 XENOGRAPH MOUSE MODEL | $42,977 | $67,329 | September 26, 2023 | November 6, 2024 | New York, NY | usaspending.gov |
| 75N93024P01130 | Department of Health and Human Services | Purchase Order | 541380 | TBDC CAPSEQ-TRANCRIPTOME ANALYSIS SERVICE | $41,250 | $41,250 | September 16, 2024 | September 15, 2025 | New York, NY | usaspending.gov |
| 19VM3026P0564 | Department of State | Purchase Order | 541380 | HANOINAMRU-IP_REACTIONS SET AND CORRESPONDING TWIST REAGENTS | $40,000 | $40,000 | August 14, 2026 | November 29, 2026 | Vietnam | usaspending.gov |
| 19GE5026P0062 | Department of State | Purchase Order | 334516 | ASSAY-SPECIFIC REAGENTS AND PROPRIETARY PRIMER/PROBE MATERIALS REQUIRED TO PERFORM THE COLUMBIA/GAPP VIRCAPSEQ WORKFLOW AT WRAIR-AFRIMS, BAN | $29,000 | $29,000 | August 11, 2026 | September 10, 2026 | Thailand | usaspending.gov |
| 19GG8026P0361 | Department of State | Purchase Order | 621511 | WRAIR_GAPP PACKAGE A | $29,000 | $29,000 | July 17, 2026 | August 30, 2026 | New York, NY | usaspending.gov |
| 75N94020F00001 | Department of Health and Human Services | Delivery Order | 541714 | TO ASSIST IN THE DEVELOPMENT OF NEW CONTRACEPTIVE PRODUCTS BY PROVIDING SERVICES RELATED TO PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVI | $14,365 | $68,093 | August 1, 2020 | July 31, 2027 | New York, NY | usaspending.gov |
| 75D30122F00007 | Department of Health and Human Services | Delivery Order | 621399 | PEDIATRIC COVID-19 VACCINATION RCT | $1,350 | $730,877 | September 29, 2022 | December 28, 2025 | New York, NY | usaspending.gov |
| 75F40121F19002 | Department of Health and Human Services | Delivery Order | 611710 | (BEST) INITIATIVE: COMMUNITY ENGAGEMENT AND DEVELOPMENT INITIATIVE FOR A CONVENER ORGANIZATION TO PROVIDE THE FDA WITH SUPPORT TO COLLABORAT | $0 | $3,567,989 | September 27, 2021 | March 7, 2025 | New York, NY | usaspending.gov |
| 75F40120D00039 | Department of Health and Human Services | IDC | 611710 | IDIQ FOR(BEST) INITIATIVE: COMMUNITY ENGAGEMENT AND DEVELOPMENT INITIATIVE FOR A CONVENER ORGANIZATION TO PROVIDE THE FDA WITH SUPPORT TO CO | $0 | $4,804,986 | September 30, 2020 | usaspending.gov | ||
| 75N94020D00013 | Department of Health and Human Services | IDC | 541714 | TO CONDUCT PHASE I, II, III OR IV CONTRACEPTIVE TRIALS IN WOMEN, TREATMENT TRIALS OF GYNECOLOGIC CONDITIONS SUCH AS ENDOMETRIOSIS OR LEIOMYO | $0 | $5,000,000 | July 31, 2020 | usaspending.gov | ||
| 80ARC023CA004 | National Aeronautics and Space Administration | Definitive Contract | 541715 | CONTRACT FOR RESEARCH AND DEVELOPMENT WORK TO EXTENDED LONGEVITY OF 3D TISSUES AND MICROPHYSIOLOGICAL SYSTEMS FOR MODELING OF ACUTE AND CHRO | $0 | $2,000,000 | November 1, 2022 | March 7, 2025 | Stanford, CA | usaspending.gov |
| 75N94023F00001 | Department of Health and Human Services | Delivery Order | 541714 | OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVI | $0 | $87,270 | September 28, 2023 | March 28, 2025 | New York, NY | usaspending.gov |
| 75A50122C00012 | Department of Health and Human Services | Definitive Contract | 541714 | TRUSTEES OF COLUMBIA UNIVERSITY VIRCAPSEQ: A PLATFORM FOR DETECTION OF PANDEMIC THREATS AND DIFFERENTIAL DIAGNOSIS OF INFECTIOUS DISEASES AO | $0 | $749,000 | March 30, 2022 | March 31, 2024 | New York, NY | usaspending.gov |
| 75N92019D00037 | Department of Health and Human Services | IDC | 541715 | REDS-IV-P DOMESTIC HUBS | $0 | $7,416,000 | April 1, 2019 | usaspending.gov | ||
| 75N92020D00002 | Department of Health and Human Services | IDC | 541715 | THE PURPOSE OF THIS STUDY IS TO MAXIMIZE USE OF RESEARCH RESOURCES AMASSED IN MESA OVER A 20-YEAR PERIOD TO ADDRESS NEW QUESTIONS ABOUT THE | $0 | $28,638,680 | December 19, 2019 | usaspending.gov | ||
| 75N98026D00096 | Department of Health and Human Services | IDC | 541715 | RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) | $0 | $17,073,000 | September 30, 2026 | usaspending.gov | ||
| 75N98026D00100 | Department of Health and Human Services | IDC | 541715 | RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY (REDS) REGIONAL HUBS | $0 | $7,416,000 | September 30, 2026 | usaspending.gov | ||
| 75N92019F00074 | Department of Health and Human Services | Delivery Order | 541715 | REDS-IV-P DOMESTIC HUBS PHASE 1 | $0 | $1,732,736 | April 1, 2019 | March 31, 2023 | New York, NY | usaspending.gov |
| 75D30123D18247 | Department of Health and Human Services | IDC | 622110 | 2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ | $0 | $86,008,000 | September 25, 2023 | usaspending.gov | ||
| 75N92026D00002 | Department of Health and Human Services | IDC | 541715 | MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) | $0 | $55,546,158 | February 13, 2026 | usaspending.gov | ||
| 75N93020C00059 | Department of Health and Human Services | Definitive Contract | 541715 | CHARACTERIZING AND IMPROVING HUMANIZED IMMUNE SYSTEM MOUSE MODELS (IMM-HIS) | $-0 | $2,198,719 | September 30, 2020 | September 29, 2024 | New York, NY | usaspending.gov |
| 75N92021F00001 | Department of Health and Human Services | Delivery Order | 541715 | MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7 | $-0 | $1,144,448 | May 19, 2021 | March 29, 2024 | New York, NY | usaspending.gov |
| HHSN27500004 | Department of Health and Human Services | Delivery Order | 541712 | IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIAL NETWORK - FEMALE SITES - EVALUATION OF LARCS STUDY | $-1 | $649,109 | September 17, 2015 | August 31, 2024 | New York, NY | usaspending.gov |
| HHSN27500003 | Department of Health and Human Services | Delivery Order | 541712 | IGF::OT::IGFCONTRACEPTIVE CLINICAL TRIAL NETWORK -CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: PILOT AND EFFICACY STUDY H | $-281 | $610,511 | September 19, 2014 | March 31, 2022 | New York, NY | usaspending.gov |
| HHSN27500002 | Department of Health and Human Services | Delivery Order | 541712 | IGF::OT::IGF A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY | $-407 | $1,672,864 | July 16, 2013 | March 31, 2022 | New York, NY | usaspending.gov |
| 75D30122C14289 | Department of Health and Human Services | Definitive Contract | 541720 | SUPPORT TRANSLATIONAL AND OPERATIONAL SCIENCE AND TECHNOLOGY ADVANCE TO IMPROVE CDC | $-1,945 | $2,205,550 | September 13, 2022 | September 12, 2024 | New York, NY | usaspending.gov |
| 75F40119C10101 | Department of Health and Human Services | Definitive Contract | 541715 | BAA FOR NEURODEVELOPMENTAL OUTCOMES IN INFANTS RECEIVING OPIOID-REPLACEMENT PHARMACOTHERAPY FOR NEONATAL OPIOID WITHDRAWAL SYNDROME(NOWS), R | $-17,720 | $1,898,794 | September 21, 2019 | August 7, 2025 | New York, NY | usaspending.gov |
| 75A50121C00017 | Department of Health and Human Services | Definitive Contract | 325413 | TO ADAPT OUR PLATFORM WITH MICRO-SIZED HUMAN TISSUES INTO A MODULAR IMMUNECHIP. TO THIS END, WE WILL BIOENGINEER ADULT-LIKE HUMAN BONE MARRO | $-27,325 | $637,675 | September 21, 2021 | November 30, 2023 | New York, NY | usaspending.gov |
| HHSD2002012536650005 | Department of Health and Human Services | Delivery Order | 621399 | IGF::OT::IGF CISACOLUMBIA UNIVERSITY MEDICAL CENTER | $-29,959 | $622,892 | September 29, 2017 | September 28, 2022 | New York, NY | usaspending.gov |
| HHSD200200723654C | Department of Health and Human Services | Definitive Contract | 923120 | KENYA HIV CARE AND TREATMENT | $-53,958 | $4,624,575 | September 28, 2007 | September 26, 2012 | Atlanta, GA | usaspending.gov |
| 75N92021F00001 | Department of Health and Human Services | Delivery Order | 541715 | REDS-IV-P DOMESTIC HUBS PHASE 2 | $-65,247 | $3,116,332 | April 1, 2021 | June 30, 2024 | Bethesda, MD | usaspending.gov |
| 75D30123C17500 | Department of Health and Human Services | Definitive Contract | 541715 | LAMP STUDY | $-341,276 | $91,531 | August 24, 2023 | August 7, 2024 | Brookhaven, GA | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541512 Computer Systems Design Services
- All recipients under NAICS 622110 General Medical and Surgical Hospitals
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 541512
- Open opportunities under NAICS 622110
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.